NovaBay Pharmaceuticals, Inc. Announces Smartphone Investor App
EMERYVILLE, Calif., Jan. 15, 2013 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, has launched its Mobile Shareholder Smartphone investor application.